Mutations that occur in response to the HIV-1 protease inhibitors are responsible for the development of multidrug cross-resistance to these antiproteases in AIDS treatment. One alternative to inhibiting the active site of HIV-1 protease is to target the dimer interface of the homodimeric enzyme at the antiparallel β-sheet formed by the interdigitation of the C- and N-ends of each monomer. This region is highly conserved and is responsible for approx. 75% of the dimer-stabilization energy. The strategies that have been used to design small molecules to target the interface antiparallel β-sheet have produced lipopeptides, guanidinium derivatives and peptides (or peptidomimetics) cross-linked with spacers. The mechanism of inhibition was determined using a combination of kinetic and biophysical methods. These dimerization inhibitors proved equally active in vitro against both wild-type and mutated proteases. They are therefore promising alternatives to active-site-directed inhibitors in AIDS therapy. Disruption of protein–protein interactions by small molecules is a new way to obtain potentially therapeutic molecules.
Skip Nav Destination
Article navigation
June 2007
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Conference Article|
May 22 2007
An alternative strategy for inhibiting multidrug-resistant mutants of the dimeric HIV-1 protease by targeting the subunit interface
L. Bannwarth;
L. Bannwarth
1Enzymologie Moléculaire et Fonctionnelle, FRE 2852, CNRS-Université Paris 6, Institut Jacques Monod, 2 place Jussieu, 75251 Cedex 05, France
Search for other works by this author on:
M. Reboud-Ravaux
M. Reboud-Ravaux
1
1Enzymologie Moléculaire et Fonctionnelle, FRE 2852, CNRS-Université Paris 6, Institut Jacques Monod, 2 place Jussieu, 75251 Cedex 05, France
1To whom correspondence should be addressed (email reboud@ccr.jussieu.fr).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
January 02 2007
Online ISSN: 1470-8752
Print ISSN: 0300-5127
© 2007 Biochemical Society
2007
Biochem Soc Trans (2007) 35 (3): 551–554.
Article history
Received:
January 02 2007
Citation
L. Bannwarth, M. Reboud-Ravaux; An alternative strategy for inhibiting multidrug-resistant mutants of the dimeric HIV-1 protease by targeting the subunit interface. Biochem Soc Trans 1 June 2007; 35 (3): 551–554. doi: https://doi.org/10.1042/BST0350551
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.